CLINICAL TRIALS PROFILE FOR CATAFLAM
✉ Email this page to a colleague
All Clinical Trials for CATAFLAM
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00276419 ↗ | Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin | Terminated | Mayo Clinic | Phase 2/Phase 3 | 2005-06-01 | The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo (10 weeks of each) for the treatment of noncyclic breast pain. |
NCT00474136 ↗ | Study to Compare the Pharmacokinetics of IV Diclofenac Sodium (2 Doses)Versus Oral Diclofenac Potassium | Completed | Javelin Pharmaceuticals | Phase 1 | 2007-03-01 | The purpose of this study is to assess the pharmacokinetic parameters of intravenous diclofenac sodium (DIC075V) 18.75 mg and 37.5 mg following single- and multiple-dose administration, as compared to oral diclofenac potassium (CataflamĀ® 50 mg), the approved reference product. |
NCT00548678 ↗ | Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers | Completed | Javelin Pharmaceuticals | Phase 1 | 2007-10-01 | This study will assess platelet function and safety in healthy male volunteers following doses of intravenous diclofenac compared to oral diclofenac (Cataflam), intravenous ketorolac and oral aspirin. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CATAFLAM
Condition Name
Clinical Trial Locations for CATAFLAM
Trials by Country
Clinical Trial Progress for CATAFLAM
Clinical Trial Phase
Clinical Trial Sponsors for CATAFLAM
Sponsor Name